【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 12
1.2 List of Figures 15
2 Introduction 16
2.1 Catalyst 16
2.2 Upcoming Related Reports 16
3 Disease Overview 17
3.1 Etiology and Pathophysiology 17
3.1.1 Etiology 17
3.1.2 Pathophysiology 17
3.1.3 Prognosis 18
3.1.4 Quality of Life 19
3.2 Symptoms 19
4 Epidemiology 20
4.1 Risk Factors 20
4.2 Global and Historical Trends 21
4.2.1 Prevalence 21
4.2.2 Diagnosed Prevalence 21
4.2.3 Diagnosed Incidence 22
4.2.4 Mortality 23
4.3 Forecast Methodology 24
4.3.1 Forecast Assumptions and Methods 26
4.4 Incident/Prevalent Cases of Prostate Cancer 27
4.4.1 Prevalent Cases of Prostate Cancer 27
4.4.2 Incident Cases of Prostate Cancer 29
4.4.3 Five-Year Relative Survival Rates 30
5 Disease Management 31
5.1 Diagnosis and Referral Overview 31
5.2 Treatment Overview 33
5.2.1 Conservative Management Strategies 37
5.2.2 Localized Treatments 38
5.2.3 Hormone Therapy 39
5.2.4 Drug Therapies 41
5.3 US 42
5.3.1 Diagnosis 42
5.3.2 Clinical Practice 42
5.4 France 44
5.4.1 Diagnosis 44
5.4.2 Clinical Practice 44
5.5 Germany 46
5.5.1 Diagnosis 46
5.5.2 Clinical Practice 46
5.6 Spain 48
5.6.1 Diagnosis 48
5.6.2 Clinical Practice 48
5.7 Italy 50
5.7.1 Diagnosis 50
5.7.2 Clinical Practice 50
5.8 UK 52
5.8.1 Diagnosis 52
5.8.2 Clinical Practice 52
5.9 Japan 54
5.9.1 Diagnosis 54
5.9.2 Clinical Practice 54
5.10 Australia 56
5.10.1 Diagnosis 56
5.10.2 Clinical Practice 56
5.11 Canada 58
5.11.1 Diagnosis 58
5.11.2 Clinical Practice 58
6 Competitive Assessment 60
6.1 Overview 60
6.2 Strategic Competitor Assessment 61
6.3 Product Profiles – Major Brands, Hormone Therapies 64
6.3.1 Zoladex (goserelin acetate) 64
6.3.2 Lupron Depot (leuprolide acetate) 68
6.3.3 Eligard (leuprolide acetate) 73
6.3.4 Trelstar (triptorelin acetate) 78
6.3.5 Firmagon (degarelix) 82
6.3.6 Casodex (bicalutamide) 86
6.4 Product Profiles – Major Brands, Chemotherapies 91
6.4.1 Taxotere (docetaxel) 91
6.4.2 Jevtana (cabazitaxel) 95
6.5 Product Profiles – Major Brands, Therapeutic Vaccines 100
6.5.1 Provenge (sipuleucil-T) 100
6.6 Product Profiles – Major Brands, Targeted Therapies 106
6.6.1 Zytiga (abiraterone acetate) 106
6.6.2 Xtandi (enzalutamide) 111
6.7 Product Profiles – Major Brands, Bone Therapies 116
6.7.1 Xgeva (denosumab) 116
6.7.2 Zometa (zoledronic acid) 120
6.8 Other Marketed Hormone and Drug Therapies 124
7 Opportunity and Unmet Need 125
7.1 Overview 125
7.2 Efficacy at Prolonging Overall Survival 126
7.3 Safety 126
7.4 Mitigation of Symptoms 127
7.5 Cost 127
7.6 Convenient Routes of Administration 127
7.7 Accurate Diagnostic Tests and Surveillance Tools 128
7.8 Unmet Needs Gap Analysis 128
7.9 Opportunity: Targeting Early-Stage, Hormone-Sensitive Prostate Cancer 130
8 Pipeline Assessment 131
8.1 Overview 131
8.2 Clinical Trial Mapping 132
8.2.1 Clinical Trials by Country 132
8.3 Clinical Trials by Phase and Trial Status 133
8.4 Promising Drugs in Clinical Development 134
8.4.1 Cabozantinib 136
8.4.2 Custirsen Sodium 141
8.4.3 Sprycel (dasatinib) 146
8.4.4 Yervoy (ipilimumab) 151
8.4.5 Orteronel 157
8.4.6 Alpharadin (radium-223 chloride) 162
8.4.7 Tasquinimod 167
8.4.8 ProstVac (Vaccinia-PSA-TRICOM/Fowlpox-PSA-TRICOM) 172
9 Current and Future Players 178
9.1 Overview 178
9.2 Trends in Corporate Strategy 179
9.3 Company Profiles 181
9.3.1 AstraZeneca 181
9.3.2 Abbott 184
9.3.3 Sanofi 186
9.3.4 Johnson & Johnson 188
9.3.5 Astellas Pharma 190
10 Market Outlook 193
10.1 Global Markets 193
10.1.1 Forecast 193
10.1.2 Drivers and Barriers – Global Issues 197
10.2 United States 201
10.2.1 Forecast 201
10.2.2 Key Events 204
10.2.3 Drivers and Barriers 204
10.3 France 207
10.3.1 Forecast 207
10.3.2 Key Events 210
10.3.3 Drivers and Barriers 211
10.4 Germany 212
10.4.1 Forecast 212
10.4.2 Key Events 215
10.4.3 Drivers and Barriers 215
10.5 Italy 217
10.5.1 Forecast 217
10.5.2 Key Events 221
10.5.3 Drivers and Barriers 221
10.6 Spain 223
10.6.1 Forecast 223
10.6.2 Key Events 226
10.6.3 Drivers and Barriers 226
10.7 United Kingdom 228
10.7.1 Forecast 228
10.7.2 Key Events 231
10.7.3 Drivers and Barriers 231
10.8 Japan 234
10.8.1 Forecast 234
10.8.2 Key Events 237
10.8.3 Drivers and Barriers 237
10.9 Australia 240
10.9.1 Forecast 240
10.9.2 Key Events 243
10.9.3 Drivers and Barriers 243
10.10 Canada 246
10.10.1 Forecast 246
10.10.2 Key Events 249
10.10.3 Drivers and Barriers 249
11 Appendix 251
11.1 Bibliography 251
11.2 Abbreviations 264
11.3 Methodology 267
11.4 Forecasting Methodology 267
11.4.1 Number of Prostate Cancer Patients Currently Seeking Treatment 267
11.4.2 Percent Drug-treated Patients 268
11.4.3 Percent Hormone Therapy-Treated Patients 268
11.4.4 Drugs Included in Each Therapeutic Class 268
11.4.5 Launch, Patent and Market Exclusivity Expiry Dates 269
11.4.6 General Pricing Assumptions 270
11.4.7 Individual Drug Assumptions 272
11.4.8 Generic Erosion 283
11.4.9 Pricing of Pipeline Agents 283
11.5 Physicians and Specialists Included in This Study 284
11.6 Survey of Prescribing Physicians 285
11.7 About the Authors 286
11.7.1 Authors 286
11.7.2 Global Head of Healthcare 287
11.8 About GlobalData 288
11.9 Contact Us 288
11.10 Disclaimer 288
【レポート販売概要】
■ タイトル：世界の前立腺がん治療薬市場予測と分析■ 英文：PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022
■ 発行日：2012年11月30日
■ 調査会社：GlobalData
■ 商品コード：GDHC29PIDR
■ 調査対象地域：グローバル
- HIV-2感染症(HIV-2 Infection)：世界の治験レビュー2014年下半期版HIV-2 Infection Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “HIV-2 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-2 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-2 Infection. It includes an overview of the trial numbers and their recruitment status as …
- 非結晶性PETの世界市場予測The global amorphous PET market is projected to reach USD 36.40 Billion by 2020, at a CAGR of 7.5% from 2015 to 2020. The bottles application segment is projected to hold the largest share in the global market in 2015, owing to increased demand of amorphous PET for the packaging of beverages. The report covers the global market across major geographical regions, which include Asia-Pacific, Europe, …
- テクニカルテキスタイルの世界市場予測Technical textiles is a global knowledge-based research-oriented industry. Since the past few years, the sector is gaining slow but steady growth worldwide due to its technical performance and functional properties in the global textiles industry. Technical textile is a special type of material or product designed for specific applications, while offering unique & exclusive characteristics that ar …
- Advate (Hemophilia A and B)：市場予測と分析（～2022）Advate (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through …
- 虫除けの世界市場2017-2021About Mosquito Repellent The global mosquito repellent market has been witnessing positive growth over the last few years and is shaping up to be one of the top competitive markets at a global level. With the globalization of different brands and increasing media coverage, consumers are becoming more aware and are adopting these products. Thus, there are signs of opportunities being created in the …
- 窓用センサーの世界市場：種類別（屋内、屋外）、用途別（商業、家庭）Window sensors are also known as door sensors and their working depends on magnet and a reed switch. The reed switch is attached to a window frame and magnet is installed on window. When the window with an armed sensor is opened, the magnet is pulled away from the reed switch and the alarm is triggered. As the windows are a potential point of entry for the intruders, window sensor is an essential …
- 世界のPasta & Noodles市場におけるニュース・イベント動向（2014年2月）Synopsis The report provides a review of the latest news and key events in the global pasta & noodles market during February 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global pasta & noodles market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events …
- 熱障壁コーティング（TBC）の世界市場分析：製品別（金属、セラミック、金属間化合物）、技術別（EB-PVD、HVOF、CVD、エアプラズマ）、コーティングコンビネーション別（セラミックYSZ、Al 2 O 3、MCrAlY、ムライトベース）、用途別（固定発電所、航空宇宙、自動車）、セグメント予測The global thermal barrier coatings market is expected to reach a market size of USD 22.30 billion by 2024, according to a new report by Grand View Research, Inc. The industry is expected to witness significant growth over the forecast period owing to the increased adoption of air plasma and vapor deposition technologies for coating application, thereby increasing the demand from various applicati …
- Saudi ArabiaのVaccines, Veterinary Use市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for vaccines, veterinary use. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on vaccines, veterinary use export/import operations in Saudi Arabia. The 2002-2 …
- ブレナー腫瘍：世界の臨床試験レビュー（2014年上半期）Brenner Tumor Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2014" provides data on the Brenner Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brenner Tumor. It includes an overview of the trial numbers and their recruitment status as per the …
- Septic Shock：グローバル臨床試験レビューH2, 2013Septic Shock Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Septic Shock Global Clinical Trials Review, H2, 2013" provides data on the Septic Shock clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Septic Shock. It includes an overview of the trial numbers and their recruitment status as per the sit …
- 月経前症候群(Premenstrual Syndrome)の治療薬パイプライン動向（2015年上半期版）Premenstrual Syndrome - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Premenstrual Syndrome - Pipeline Review, H1 2015’, provides an overview of the Premenstrual Syndrome’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Premenstrual Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug t …
- Dental Chairs and Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Dental Chairs and Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Dental Chairs and Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Dental Chairs and Equipment market in the BRICS countries. The report provides value ($m), volume (units) and average price …
- スマートフォン/タブレットPC用アクセサリー及び周辺機器の世界市場Covering: This market study segments the global accessories and peripherals market for smartphones and tablets by product ( cases, screen guards, headsets, and chargers) and by geography (APAC, EMEA, and the Americas). Leading vendors in this market are Belkin, Logitech, Otter Products, Targus, and Zagg. Market outlook of the global accessories and peripherals market for smartphones and tablets Ac …
- バルーン椎骨形成の世界市場2015-2019About Balloon Kyphoplasty VCF is characterized by the collapse of one or more vertebral bodies, resulting in persistent and unbearable pain in patients. Osteoporosis, a degenerative bone disease, is a leading cause of VCF among elderly women. Metastatic bone disease, multiple myeloma, metastatic spinal tumors, and traumatic injuries also cause VCF. Individuals with VCF can undergo vertebroplasty a …
